EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY 4.0

Translational Validation of a Novel Multi-Locus ctDNA Methylation Assay for Early Detection and Stratification of Colorectal Cancer: An Exploratory Prospective, Case-Control Study

Hayoung Lee iD, Jae Cheol Kang iD, In Ja Park iD, Gwang-Un Kim iD, Hwi Hyun, Na Young Min, Sungwon Jeon, Byoung-Chul Kim

International Journal of Molecular Sciences · 25.06.2026 · 27 (13) · 5738

DOI: 10.3390/ijms27135738 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.06.2026. Verfasst von Hayoung Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colon and Rectal Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea. Hauptthemen laut MEDLINE: DNA Methylation, Colorectal Neoplasms, Biomarkers, Tumor, Circulating Tumor DNA. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To evaluate the diagnostic performance and clinicopathologic relevance of a multi-locus circulating tumor DNA methylation assay, in this prospective, single-center, case-control exploratory study, we enrolled 35 patients with colorectal cancer undergoing surgery and 57 healthy controls undergoing screening colonoscopy at the Asan Medical Center, Seoul, Republic of Korea between July 2024 and January 2025. Peripheral blood was collected before surgery or colonoscopy, and circulating tumor DNA methylation was analyzed using a multi-locus panel targeting Septin9, IKZF1, BCAT1, Septin9-2, BCAN, and VAV3. The main outcomes were test accuracy (sensitivity, specificity, and area under the curve [AUC]) and associations between methylation marker positivity and clinicopathologic features. Circulating tumor DNA was positive in 74.3% of the patients and 12.3% of controls, yielding a sensitivity of 74.3%, specificity of 87.7%, and an AUC of 0.837, whereas serum carcinoembryonic antigen exhibited lower sensitivity (25.7%). Sensitivity in stage I disease was limited (36.4%). Circulating tumor DNA-positive tumors were larger (5.7 cm vs. 2.2 cm, p < 0.001) and had more advanced T and N stages. The number of positive markers increased with pathologic stage (p = 0.003). Individual marker analysis revealed that BCAT1, Septin9-2, and VAV3 were associated with higher T stage, whereas BCAN positivity was linked to nodal metastasis. The six-marker circulating tumor DNA methylation assay demonstrated acceptable diagnostic accuracy, with multi-locus patterns associated with tumor burden and invasive features. However, sensitivity for early-stage disease was limited. The assay may serve as a complementary tool for screening and risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationColorectal NeoplasmsBiomarkers, TumorCirculating Tumor DNAEarly Detection of CancerHumansFemaleCase-Control StudiesMaleMiddle AgedProspective StudiesSeptinsAgedProto-Oncogene Proteins c-vavTransaminasesSensitivity and Specificity

Stichwörter der Autor:innen

DNA methylationcolorectal neoplasmsliquid biopsy

Substanzen

Biomarkers, TumorSEPTIN9 protein, humanSeptinsCirculating Tumor DNAVAV3 protein, humanProto-Oncogene Proteins c-vavBCAT1 protein, humanTransaminases

Autor:innen und Institutionen

  • Department of Colon and Rectal Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
  • Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul 02447, Republic of Korea.
  • Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
  • Clinomics Inc., Ulsan 44919, Republic of Korea.
  • Evergenome Inc., Eungubinam-ro 33beon-gil, Jijeok-dong, Yuseong-gu, Daejeon 34086, Republic of Korea.
  • AgingLab Inc., Ulsan 44919, Republic of Korea.

ORCID-Profile: Hayoung Lee, Jae Cheol Kang, In Ja Park, Gwang-Un Kim

Zitieren

APA

Lee, H., Kang, J. C., Park, I. J., Kim, G. U., Hyun, H., Min, N. Y., Jeon, S., & Kim, B. C. (2026). Translational Validation of a Novel Multi-Locus ctDNA Methylation Assay for Early Detection and Stratification of Colorectal Cancer: An Exploratory Prospective, Case-Control Study. International Journal of Molecular Sciences, 27(13), 5738. https://doi.org/10.3390/ijms27135738

Vancouver

Lee H, Kang JC, Park IJ, Kim GU, Hyun H, Min NY, et al. Translational Validation of a Novel Multi-Locus ctDNA Methylation Assay for Early Detection and Stratification of Colorectal Cancer: An Exploratory Prospective, Case-Control Study. International Journal of Molecular Sciences. 2026;27(13):5738. doi:10.3390/ijms27135738

BibTeX
@article{Lee2026,
  author = {Lee, Hayoung and Kang, Jae Cheol and Park, In Ja and Kim, Gwang-Un and Hyun, Hwi and Min, Na Young and Jeon, Sungwon and Kim, Byoung-Chul},
  title = {Translational Validation of a Novel Multi-Locus ctDNA Methylation Assay for Early Detection and Stratification of Colorectal Cancer: An Exploratory Prospective, Case-Control Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {13},
  pages = {5738},
  doi = {10.3390/ijms27135738}
}
Kostenlos starten →